FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280495980> ?p ?o ?g. }

• W4280495980 abstract "Introduction. Atherosclerosis is a chronic disorder in which plaque builds up in the arteries and is associated with several cardiovascular and cerebrovascular diseases such as coronary artery disease, cerebral infarction and cerebral haemorrhage. Therefore, there is an urgent need to discover new medications to treat or prevent atherosclerosis.Hypothesis/Gap Statement. The active components of Guanxin Xiaoban capsules may have an effect on the gut microbiome of patients with atherosclerosis and have a role in their therapeutic targets.Aim. The aim of this study was to identify genes and pathways targeted by active ingredients in Guanxin Xiaoban capsules for the treatment of atherosclerosis based on network pharmacology and analysis of changes to the gut microbiome.Methods. Mice were treated with Guanxin Xiaoban capsules. The 16S rDNA genome sequence of all microorganisms from each group of faecal samples was used to evaluate potential structural changes in the gut microbiota after treatment with Guanxin Xiaoban capsules. Western blotting and real-time quantitative PCR were used to detect gene targets in aortic and liver tissues. Haematoxylin and eosin staining was used to observe improvements in mouse arterial plaques.Results. The gut microbiota of atherosclerotic mice is disturbed. After Guanxin Xiaoban treatment, the abundance of bacteria in the mice improved, with an increase in the proportion of Akkermansia and a significant decrease in the proportion of Faecalibaculum. The main ingredients of Guanxin Xiaoban capsules are calycosin, liquiritin, ferulic acid, ammonium glycyrrhizate, aloe emodin, rhein and emodin. The core genes of this network were determined to be glutathione S-transferase mu 1 (GSTM1), vascular endothelial growth factor A (VEGFA) and cyclin-dependent kinase inhibitor 1A (CDKN1A). The compound-target gene network revealed an interaction between multiple components and targets and contributed to a better understanding of the potential therapeutic effects of the capsules on atherosclerosis. In addition, expression of the AGE-receptor for the AGE (RAGE) pathway was significantly inhibited and the mice showed signs of arterial plaque reduction. Guanxin Xiaoban capsules may improve atherosclerosis and reduce the plaque area by inhibiting the AGE-RAGE signalling pathway to delay the development of atherosclerosis. This mechanism appears to involve changes in the gut microbiota. Therefore, Guanxin Xiaoban capsules have potential value as a treatment for atherosclerosis." @default.
• W4280495980 created "2022-05-22" @default.
• W4280495980 creator A5013196872 @default.
• W4280495980 creator A5023759086 @default.
• W4280495980 creator A5033729931 @default.
• W4280495980 creator A5043693897 @default.
• W4280495980 creator A5045281956 @default.
• W4280495980 creator A5049695869 @default.
• W4280495980 creator A5061624104 @default.
• W4280495980 creator A5074094425 @default.
• W4280495980 creator A5076431692 @default.
• W4280495980 creator A5087657305 @default.
• W4280495980 date "2022-05-17" @default.
• W4280495980 modified "2023-09-25" @default.
• W4280495980 title "Guanxin Xiaoban capsules could treat atherosclerosis by affecting the gut microbiome and inhibiting the AGE–RAGE signalling pathway" @default.
• W4280495980 cites W2011995221 @default.
• W4280495980 cites W2012278396 @default.
• W4280495980 cites W2057448387 @default.
• W4280495980 cites W2090925778 @default.
• W4280495980 cites W2114688115 @default.
• W4280495980 cites W2124679671 @default.
• W4280495980 cites W2129902595 @default.
• W4280495980 cites W2133929625 @default.
• W4280495980 cites W2145478166 @default.
• W4280495980 cites W2159339965 @default.
• W4280495980 cites W2159527861 @default.
• W4280495980 cites W2171016495 @default.
• W4280495980 cites W2285914316 @default.
• W4280495980 cites W2321122078 @default.
• W4280495980 cites W2330615626 @default.
• W4280495980 cites W2567483554 @default.
• W4280495980 cites W2590902687 @default.
• W4280495980 cites W2598102406 @default.
• W4280495980 cites W2736172938 @default.
• W4280495980 cites W2765733390 @default.
• W4280495980 cites W2769465037 @default.
• W4280495980 cites W2887744807 @default.
• W4280495980 cites W2891072248 @default.
• W4280495980 cites W2894528081 @default.
• W4280495980 cites W2913620138 @default.
• W4280495980 cites W2940659656 @default.
• W4280495980 cites W2996109213 @default.
• W4280495980 cites W2999328395 @default.
• W4280495980 cites W3007498336 @default.
• W4280495980 cites W3011102399 @default.
• W4280495980 cites W3091594428 @default.
• W4280495980 cites W3192070375 @default.
• W4280495980 doi "https://doi.org/10.1099/jmm.0.001530" @default.
• W4280495980 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35580023" @default.
• W4280495980 hasPublicationYear "2022" @default.
• W4280495980 type Work @default.
• W4280495980 citedByCount "0" @default.
• W4280495980 crossrefType "journal-article" @default.
• W4280495980 hasAuthorship W4280495980A5013196872 @default.
• W4280495980 hasAuthorship W4280495980A5023759086 @default.
• W4280495980 hasAuthorship W4280495980A5033729931 @default.
• W4280495980 hasAuthorship W4280495980A5043693897 @default.
• W4280495980 hasAuthorship W4280495980A5045281956 @default.
• W4280495980 hasAuthorship W4280495980A5049695869 @default.
• W4280495980 hasAuthorship W4280495980A5061624104 @default.
• W4280495980 hasAuthorship W4280495980A5074094425 @default.
• W4280495980 hasAuthorship W4280495980A5076431692 @default.
• W4280495980 hasAuthorship W4280495980A5087657305 @default.
• W4280495980 hasConcept C143121216 @default.
• W4280495980 hasConcept C60644358 @default.
• W4280495980 hasConcept C71924100 @default.
• W4280495980 hasConcept C86803240 @default.
• W4280495980 hasConceptScore W4280495980C143121216 @default.
• W4280495980 hasConceptScore W4280495980C60644358 @default.
• W4280495980 hasConceptScore W4280495980C71924100 @default.
• W4280495980 hasConceptScore W4280495980C86803240 @default.
• W4280495980 hasIssue "5" @default.
• W4280495980 hasLocation W42804959801 @default.
• W4280495980 hasLocation W42804959802 @default.
• W4280495980 hasOpenAccess W4280495980 @default.
• W4280495980 hasPrimaryLocation W42804959801 @default.
• W4280495980 hasRelatedWork W2424057235 @default.
• W4280495980 hasRelatedWork W2538250210 @default.
• W4280495980 hasRelatedWork W2902095886 @default.
• W4280495980 hasRelatedWork W2953012543 @default.
• W4280495980 hasRelatedWork W2989997703 @default.
• W4280495980 hasRelatedWork W3135807260 @default.
• W4280495980 hasRelatedWork W3174133677 @default.
• W4280495980 hasRelatedWork W4229368354 @default.
• W4280495980 hasRelatedWork W4294124809 @default.
• W4280495980 hasRelatedWork W4309412997 @default.
• W4280495980 hasVolume "71" @default.
• W4280495980 isParatext "false" @default.
• W4280495980 isRetracted "false" @default.
• W4280495980 workType "article" @default.